Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
The OptiZest study aims to investigate a personalised dose of Zestril in these patients
Read More
Tag: pharmanovia
Pharmanovia and Closed Loop Medicine in precision medicine partnership
Dosing optimisation technology will be incorporated alongside anti-hypertensive drugs
Read More
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
